FOLLOWING the NZ Medsafe "potential risk" alert around joint-support product Arthrem, from Promisia and marketed by Pharmabroker, Promisia explains it is safe when taken "strictly as directed" - see the full story on two pages after the news in today's issue of Pharmacy Daily.
The above article was sent to subscribers in Pharmacy Daily's issue from 20 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 20 Feb 18
